![Aktiia demonstrates at AHA Hypertension Scientific Sessions 2022 that the persistent use of a 24/7 cuffless monitor is associated with lower blood pressure in hypertensive subjects Aktiia demonstrates at AHA Hypertension Scientific Sessions 2022 that the persistent use of a 24/7 cuffless monitor is associated with lower blood pressure in hypertensive subjects](https://mma.prnewswire.com/media/1895542/Aktiaa_appandwatch.jpg)
Aktiia demonstrates at AHA Hypertension Scientific Sessions 2022 that the persistent use of a 24/7 cuffless monitor is associated with lower blood pressure in hypertensive subjects
![Swiss startup Aktiia receives CE mark for continuous blood pressure monitoring system | MobiHealthNews Swiss startup Aktiia receives CE mark for continuous blood pressure monitoring system | MobiHealthNews](https://www.mobihealthnews.com/sites/default/files/Aktiia%20Real%20Case%201.jpg)
Swiss startup Aktiia receives CE mark for continuous blood pressure monitoring system | MobiHealthNews
![Aktiia demonstrates at AHA Hypertension Scientific Sessions 2022 that the persistent use of a 24/7 cuffless monitor is associated with lower blood pressure in hypertensive subjects Aktiia demonstrates at AHA Hypertension Scientific Sessions 2022 that the persistent use of a 24/7 cuffless monitor is associated with lower blood pressure in hypertensive subjects](https://mma.prnewswire.com/media/1895543/Aktiia_Graph_Infographic.jpg?p=facebook)